U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry RACEMIC
Molecular Formula C15H22N2O
Molecular Weight 246.348
Optical Activity ( + / - )
Defined Stereocenters 2 / 2
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of MILNACIPRAN

SMILES

CCN(CC)C(=O)[C@@]1(C[C@@H]1CN)C2=CC=CC=C2

InChI

InChIKey=GJJFMKBJSRMPLA-HIFRSBDPSA-N
InChI=1S/C15H22N2O/c1-3-17(4-2)14(18)15(10-13(15)11-16)12-8-6-5-7-9-12/h5-9,13H,3-4,10-11,16H2,1-2H3/t13-,15+/m1/s1

HIDE SMILES / InChI

Approval Year

Unknown
86413
Name Type Language
MILNACIPRAN
EMA EPAR   INN   MI   VANDF   WHO-DD  
INN  
Official Name English
Milnacipran [WHO-DD]
Common Name English
MILNACIPRAN [MI]
Common Name English
milnacipran [INN]
Common Name English
(1RS,2SR)-2-(AMINOMETHYL)-N,N-DIETHYL-1-PHENYLCYCLOPROPANECARBOXAMIDE
Systematic Name English
MILNACIPRAN [VANDF]
Common Name English
IMPULSOR
Brand Name English
MILNACIPRAN [EMA EPAR]
Common Name English
MILNACIPRAN PIERRE FABRE MEDICAMENT
Brand Name English
CYCLOPROPANECARBOXAMIDE, 2-(AMINOMETHYL)-N,N-DIETHYL-1-PHENYL-, (1R,2S)-REL-
Systematic Name English
Classification Tree Code System Code
NCI_THESAURUS C29747
Created by admin on Fri Dec 15 16:37:03 UTC 2023 , Edited by admin on Fri Dec 15 16:37:03 UTC 2023
WHO-VATC QN06AX17
Created by admin on Fri Dec 15 16:37:03 UTC 2023 , Edited by admin on Fri Dec 15 16:37:03 UTC 2023
EMA ASSESSMENT REPORTS IMPULSOR (REFUSED, FIBROMYALGIA)
Created by admin on Fri Dec 15 16:37:03 UTC 2023 , Edited by admin on Fri Dec 15 16:37:03 UTC 2023
NDF-RT N0000000109
Created by admin on Fri Dec 15 16:37:03 UTC 2023 , Edited by admin on Fri Dec 15 16:37:03 UTC 2023
NCI_THESAURUS C265
Created by admin on Fri Dec 15 16:37:03 UTC 2023 , Edited by admin on Fri Dec 15 16:37:03 UTC 2023
NDF-RT N0000175749
Created by admin on Fri Dec 15 16:37:03 UTC 2023 , Edited by admin on Fri Dec 15 16:37:03 UTC 2023
NDF-RT N0000000102
Created by admin on Fri Dec 15 16:37:03 UTC 2023 , Edited by admin on Fri Dec 15 16:37:03 UTC 2023
LIVERTOX NBK547960
Created by admin on Fri Dec 15 16:37:03 UTC 2023 , Edited by admin on Fri Dec 15 16:37:03 UTC 2023
EMA ASSESSMENT REPORTS MILNACIPRAN PIERRE FABRE MEDICAMENT (REFUSED: FIBROMYALGIA)
Created by admin on Fri Dec 15 16:37:03 UTC 2023 , Edited by admin on Fri Dec 15 16:37:03 UTC 2023
WHO-ATC N06AX17
Created by admin on Fri Dec 15 16:37:03 UTC 2023 , Edited by admin on Fri Dec 15 16:37:03 UTC 2023
EMA ASSESSMENT REPORTS IMPULSOR (REFUSED: FIBROMYALGIA)
Created by admin on Fri Dec 15 16:37:03 UTC 2023 , Edited by admin on Fri Dec 15 16:37:03 UTC 2023
Code System Code Type Description
MESH
C048107
Created by admin on Fri Dec 15 16:37:03 UTC 2023 , Edited by admin on Fri Dec 15 16:37:03 UTC 2023
PRIMARY
RXCUI
588250
Created by admin on Fri Dec 15 16:37:03 UTC 2023 , Edited by admin on Fri Dec 15 16:37:03 UTC 2023
PRIMARY RxNorm
WIKIPEDIA
MILNACIPRAN
Created by admin on Fri Dec 15 16:37:03 UTC 2023 , Edited by admin on Fri Dec 15 16:37:03 UTC 2023
PRIMARY
PUBCHEM
65833
Created by admin on Fri Dec 15 16:37:03 UTC 2023 , Edited by admin on Fri Dec 15 16:37:03 UTC 2023
PRIMARY
NCI_THESAURUS
C78021
Created by admin on Fri Dec 15 16:37:03 UTC 2023 , Edited by admin on Fri Dec 15 16:37:03 UTC 2023
PRIMARY
IUPHAR
7436
Created by admin on Fri Dec 15 16:37:03 UTC 2023 , Edited by admin on Fri Dec 15 16:37:03 UTC 2023
PRIMARY
ChEMBL
CHEMBL259209
Created by admin on Fri Dec 15 16:37:03 UTC 2023 , Edited by admin on Fri Dec 15 16:37:03 UTC 2023
PRIMARY
FDA UNII
G56VK1HF36
Created by admin on Fri Dec 15 16:37:03 UTC 2023 , Edited by admin on Fri Dec 15 16:37:03 UTC 2023
PRIMARY
SMS_ID
100000080634
Created by admin on Fri Dec 15 16:37:03 UTC 2023 , Edited by admin on Fri Dec 15 16:37:03 UTC 2023
PRIMARY
EPA CompTox
DTXSID3048287
Created by admin on Fri Dec 15 16:37:03 UTC 2023 , Edited by admin on Fri Dec 15 16:37:03 UTC 2023
PRIMARY
MERCK INDEX
m7545
Created by admin on Fri Dec 15 16:37:03 UTC 2023 , Edited by admin on Fri Dec 15 16:37:03 UTC 2023
PRIMARY Merck Index
LACTMED
Milnacipran
Created by admin on Fri Dec 15 16:37:03 UTC 2023 , Edited by admin on Fri Dec 15 16:37:03 UTC 2023
PRIMARY
DRUG BANK
DB04896
Created by admin on Fri Dec 15 16:37:03 UTC 2023 , Edited by admin on Fri Dec 15 16:37:03 UTC 2023
PRIMARY
INN
5701
Created by admin on Fri Dec 15 16:37:03 UTC 2023 , Edited by admin on Fri Dec 15 16:37:03 UTC 2023
PRIMARY
DAILYMED
G56VK1HF36
Created by admin on Fri Dec 15 16:37:03 UTC 2023 , Edited by admin on Fri Dec 15 16:37:03 UTC 2023
PRIMARY
DRUG CENTRAL
1808
Created by admin on Fri Dec 15 16:37:03 UTC 2023 , Edited by admin on Fri Dec 15 16:37:03 UTC 2023
PRIMARY
CAS
92623-85-3
Created by admin on Fri Dec 15 16:37:03 UTC 2023 , Edited by admin on Fri Dec 15 16:37:03 UTC 2023
PRIMARY
EVMPD
SUB08965MIG
Created by admin on Fri Dec 15 16:37:03 UTC 2023 , Edited by admin on Fri Dec 15 16:37:03 UTC 2023
PRIMARY
ACTIVE MOIETY
Structure of MILNACIPRAN
METABOLITE (PARENT)
Structure of N-DESETHYL MILNACIPRAN
SALT/SOLVATE (PARENT)
Structure of MILNACIPRAN HYDROCHLORIDE
NIH
NCATS
PRIVACY ACT
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966